Pacific Edge, a cancer diagnostic company listed on the NZX and ASX, is urgently seeking to raise $24 million to avoid collapse. The company's cash reserves have diminished, and revenue has fallen. The company's CEO is Peter Meintjes. Its shares are in a trading halt until Wednesday morning during a placement of $18m new shares to eligible investors. The article was published on May 11, 2026.